1. Home
  2. BCDA vs OMEX Comparison

BCDA vs OMEX Comparison

Compare BCDA & OMEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCDA
  • OMEX
  • Stock Information
  • Founded
  • BCDA N/A
  • OMEX 1986
  • Country
  • BCDA United States
  • OMEX United States
  • Employees
  • BCDA N/A
  • OMEX N/A
  • Industry
  • BCDA Biotechnology: Pharmaceutical Preparations
  • OMEX Marine Transportation
  • Sector
  • BCDA Health Care
  • OMEX Consumer Discretionary
  • Exchange
  • BCDA Nasdaq
  • OMEX Nasdaq
  • Market Cap
  • BCDA 7.9M
  • OMEX 9.3M
  • IPO Year
  • BCDA N/A
  • OMEX N/A
  • Fundamental
  • Price
  • BCDA $2.18
  • OMEX $0.70
  • Analyst Decision
  • BCDA Strong Buy
  • OMEX
  • Analyst Count
  • BCDA 1
  • OMEX 0
  • Target Price
  • BCDA $25.00
  • OMEX N/A
  • AVG Volume (30 Days)
  • BCDA 52.4K
  • OMEX 2.4M
  • Earning Date
  • BCDA 11-13-2024
  • OMEX 02-19-2025
  • Dividend Yield
  • BCDA N/A
  • OMEX N/A
  • EPS Growth
  • BCDA N/A
  • OMEX N/A
  • EPS
  • BCDA N/A
  • OMEX N/A
  • Revenue
  • BCDA $71,000.00
  • OMEX $799,139.00
  • Revenue This Year
  • BCDA N/A
  • OMEX N/A
  • Revenue Next Year
  • BCDA N/A
  • OMEX N/A
  • P/E Ratio
  • BCDA N/A
  • OMEX $1.23
  • Revenue Growth
  • BCDA N/A
  • OMEX N/A
  • 52 Week Low
  • BCDA $1.63
  • OMEX $0.30
  • 52 Week High
  • BCDA $8.85
  • OMEX $5.57
  • Technical
  • Relative Strength Index (RSI)
  • BCDA 49.10
  • OMEX 60.89
  • Support Level
  • BCDA $2.05
  • OMEX $0.62
  • Resistance Level
  • BCDA $2.36
  • OMEX $0.71
  • Average True Range (ATR)
  • BCDA 0.21
  • OMEX 0.10
  • MACD
  • BCDA -0.00
  • OMEX 0.00
  • Stochastic Oscillator
  • BCDA 46.43
  • OMEX 52.72

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About OMEX Odyssey Marine Exploration Inc.

Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodule (battery metals) projects. Its projects include ExO Phosphate project, CIC, Ocean Minerals, and LIHIR Gold project.

Share on Social Networks: